Mahavir Advanced Remedies Profile
Key Indicators
- Authorised Capital ₹ 15.50 Cr
- Paid Up Capital ₹ 11.36 Cr
- Company Age 32 Year, 9 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 9.00 M
About Mahavir Advanced Remedies
Mahavir Advanced Remedies Limited (MARL) is a Public Limited Indian Non-Government Company incorporated in India on 29 April 1992 and has a history of 32 years and nine months. Its registered office is in Chennai, Tamil Nadu.
The Corporate was formerly known as Indo-American Advanced Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 15.50 Cr and a paid-up capital of Rs 11.36 Cr.
The company currently has active open charges totaling ₹9.00 M.
Mani Rao, Shantilal Purohit, and Sanjay Kumar serve as directors at the Company.
Company Details
- LocationChennai, Tamil Nadu
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
L24231TN1992PLC022562
- Company No.
022562
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Apr 1992
- Date of AGM
30 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Listed
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Mahavir Advanced Remedies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mani Rao  | Director | 02-Mar-2012 | Current |
| Shantilal Purohit | Director | 22-May-2013 | Current |
| Sanjay Kumar | Additional Director | 14-Jan-2015 | Current |
Financial Performance of Mahavir Advanced Remedies.
Enhance accessibility to Mahavir Advanced Remedies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mahavir Advanced Remedies?
Unlock access to Mahavir Advanced Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Naturo-Pest LimitedSanjay Kumar is a mutual person
Charges (Loans)
₹0.90 Cr
₹0
Charges Breakdown by Lending Institutions
- A. P. State Financial Corporation : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Nov 1997 | A. P. State Financial Corporation | ₹9.00 M | Open |
How Many Employees Work at Mahavir Advanced Remedies?
Unlock and access historical data on people associated with Mahavir Advanced Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahavir Advanced Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahavir Advanced Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
